NovaBay Pharmaceuticals, Inc. (NBY) Reports Third Quarter 2013 Financial Results And A Clinical/Business Update
11/14/2013 1:24:40 PM
EMERYVILLE, Calif., Nov. 14, 2013 (GLOBE NEWSWIRE) -- NovaBay Pharmaceuticals, Inc. (NYSE MKT:NBY), a clinical-stage biopharmaceutical company developing non-antibiotic antimicrobial products, today reported third quarter 2013 financial results and provided a clinical update.
Help employers find you! Check out all the jobs and post your resume.
comments powered by